References
- Burney P GJ, Chinn S, Rona R J. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973–1986. Br Med J 1990; 300: 1306–1310
- Pearce N, Douwes J, Beasley R. The rise and rise of asthma: A new paradigm for the new millennium?. J Epidemiol Biostat 2000; 5: 5–16
- Soler M, Chatenoud L, Negri E, La Vecchia C. Trends in asthma mortality in Italy and Spain, 1980–1996. Eur. J. Epidemiol. 2001; 17: 545–549
- Cadet B, Robine J M, Leibovici D. Dynamique de la mortality asthmatique en France: Fluctuations saisonnieres et crise de mortalite' en 1985–1987. Rev Epidem et Sante' Publ 1994; 42: 103–118
- La Vecchia C, Levi F, Lucchini F. Trends in mortalita from bronchial asthma in Switzerland, 1969–1993. Rev Epidem et Sante' Publ 1996; 44: 155–161
- Beasley R, Pearce N, Crane J, Burgess C. β -agonists: What is the evidence that their use increases the risk of asthma morbidity and mortality?. J Allergy Clin Immunol 1999; 103: S18–30
- Sin D D, Man J, Sharpe H, Gan W Q, Man S F. Pharmacological management to reduce exacerbations in adults with asthma. A systematic review and meta-analysis. JAMA 2004; 292: 367–376
- Speizer F E, Doll R, Heaf D P. Investigation into the use of drugs preceding death from asthma. BMJ 1968; 1: 229–243
- Inman W H, Adelstein A M. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet 1969; 2: 279–285
- Burney P G. Asthma mortality in England and Wales: Evidence for a further increase, 1974–1984. Lancet 1986; 2: 323–326
- Anderson H R, Gupta R, Strachan D P, Limb E S. 50 years of asthma: UK trends from 1955 to 2004. Thorax 2007; 62: 85–90
- Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981–1983: Case-control study. Lancet 1989; 1: 917–922
- Pearce N, Beasley R, Crane J, Burgess C, Jackson R. End of the New Zealand asthma mortality epidemic. Lancet 1995; 345: 41–44
- Walters E H, Gibson P G, Lasserson T J, Walters J A. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. Cochrane Database of Systematic Reviews 2007, Issue 1. Art.: CD001385
- Salpeter S R, Buckley N S, Ormiston T M, Salpeter E E. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006; 144: 904–912
- Nelson H S, Weiss S T, Bleecker E R, Yancey S W, Dorinsky PM; SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129: 15–26
- Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993; 306: 1034–1037
- Glassroth J. The role of long-acting β2-agonists in the management of asthma: analysis, meta-analysis and more analysis. Ann Intern Med 2006; 144: 936–937
- European Commission, Available at: http://epp.eurostat.ec.europa.eu/portal/page?_pageid=1090,30070682,1090_30298591&_dad=portal&_schema=PORTAL Eurostat (home Page (accessed July 17 2006 and December 21 2006)
- Doll R, Smith P G. Comparison between registries: age-standardized rates. Cancer incidence in five continents, J AH Waterhouse, C S Muir, K Shanmugaratnam, J Powell, D Peacham, S Whelan. IARC, Lyon 1982; Vol. 4, IARC Scientific publication 42, 671-5
- National Cancer Institute. Joinpoint regression Program, version 3.0. September, 2006, Available at http://srab.cancer.gov/joinpoint
- Kim H J, Fay M P, Feuer E J, Midthune D N. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335–51, Erratum in 2001; 20;655
- La Vecchia C, Fasoli M, Negri E, Tognoni G. Fall and rise in asthma mortality in Italy, 1968–1984. Int J Epidemiol 1989; 18: 998–999
- Mormile F, Chiappini F, Feola G, Ciappi G. Deaths from asthma in Italy (1974–1988): Is there a relationship with changing pharmacological approaches?. J Clin Epidemiol 1996; 49: 1459–1466
- Romano F, Recchia G, Staniscia T, Bonitatibus A, Villa M, Nicolosi A, De Carli G, Mannino S. Rise and fall of asthma-related mortality in Italy and sales of β2-agonists, 1980–1994. Eur J Epidemiol 2000; 16: 783–787
- Jenkins M A, Hurley S F, Bowes G, McNeil J J. Use of antiasthmatic drugs in Australia. Med J Aust 1990; 153: 323–328
- Melissinos C, Gourgoulianis K, Adamidis S. Inhaled Drug Consumption and Asthma Mortality in Greece. Chest 1995; 107: 1771–1772
- Eder W, Ege M J, von Mutius E. The Asthma Epidemic. N Engl J Med 2006; 355: 2226–2235
- National Institutes of Health. Global strategy for asthma management and prevention. National Institutes of Health, Betesda, MD 2004, NIH publication 02–3659
- O'Byrne P M, Adelroth E. β 2 Déjà vu. Chest 2006; 129: 3–5
- Rider N L, Craig T J. A safety review of long-acting beta2-agonists in patients with asthma. J Am Osteopath Assoc 2006; 106: 562–567
- Gupta R, Anderson H R, Strachan D P, Maier W, Watson L. International trends in admissions and drug sales for asthma. Int J Tuberc Lung Dis 2006; 10: 138–145
- Suissa S, Ernst P. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic. J Clin Epidemiol 1997; 50: 1079–1088
- Shelley M, Croft P, Chapman S, Pantin C. Is the quality of asthma prescribing, as measured by the general practice ratio of corticosteroid to bronchodilator, associated with asthma morbidity?. J Clin Epidemiol 2000; 53: 1217–1221
- Stafford R S, Ma J, Finkelstein S N, Haver K, Cockburn I. National trends in asthma visits and asthma pharmacotherapy, 1978–2002. J Allergy Clin Immunol 2003; 111: 729–735
- Krawiec M E, Jarjour N J. Leukotriene receptor antagonists. Semin Respir Crit Care Med 2002; 23: 399–410
- Deykin A, Wechsler M E, Boushey H A, Chinchilli V M, Kunselman S J, Craig T J, DiMango E, Fahy J V, Kraft M, Leone F, Lazarus S C, Lemanske R F, Jr, Martin R J, Pesola G R, Peters S P, Sorkness C A, Szefler S J, Israel E, National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med 2007; 175: 228–234
- Ducharme F M, Lasserson T J, Cates C J. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database of Systematic Reviews 2006, Issue 4 Art.:CD003137
- Campbell M J, Cogman G R, Holgate S T, Johnston S L. Age-specific trends in asthma mortality in England and Wales, 1983–1995: Results of an observational study. Br Med J 1997; 314: 1439–1441
- Hunt L W, Jr, Silverstein M D, Reed C E, O'Connell E J, O'Fallon W M, Yunginger J W. Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA 1993; 269: 1947–1952
- Rutstein D D, Berenberg W, Chalmers T C, Fishman A P, Perrin E B, Zuidema G D. Measuring the quality of medical care: second revision of tables of indexes. N Engl J Med 1980; 302: 1146